Indefinite Delivery Contract SPE2DR25D9992

The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to various Department of Defense (DoD) customers, including the Defense Health Agency and the U.S. Coast Guard.

The $499,999,999 IDC, valid through November 2026, allows DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across multiple product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract is a critical component of the DLA Troop Support Medical Supply Chain's Pharmaceutical Prime Vendor Global Program Generation V, which aims to establish multiple prime vendor contracts to provide worldwide pharmaceutical support to DoD customers. The contract is an unrestricted, fully competitive acquisition awarded on a lowest price technically acceptable basis, with the intent to use reverse auctions to secure the best distribution fees for the primary suppliers.